Researchers recently evaluated a multidisciplinary referral pathway to improve congenital Chagas disease screening in nonendemic regions. This parasitic infection, caused by Trypanosoma cruzi, affects approximately 5–10% of pregnancies in infected women. Specifically, because most cases in newborns are asymptomatic, clinicians often miss maternal infections unless they maintain a high index of suspicion. Early detection is vital. This is because antiparasitic treatment in infancy yields significantly higher cure rates than interventions administered later in life.

Optimizing Congenital Chagas Disease Screening Protocols

The pilot program established a specific adult-pediatric disease referral pathway to bridge the gap in care. Moreover, the team developed a clinic dedicated to screening children born to women previously diagnosed with Chagas disease. Out of 28 referred children, 23 attended the clinic and 22 underwent testing. Consequently, the team identified one child with congenital infection, enabling timely treatment. This multidisciplinary approach proves effective and beneficial for both parents and healthcare professionals.

Addressing Barriers to Maternal-Fetal Health

While the service received positive feedback, practitioners must address barriers to accessing prior testing to ensure universal coverage. Furthermore, this model offers a valuable blueprint for nonendemic countries, including India, where increasing international migration may lead to imported cases. Systematic catch-up testing ensures that no child falls through the cracks of the healthcare system. Therefore, by integrating maternal health data with pediatric follow-ups, hospitals can significantly reduce the long-term burden of chronic Chagas-related complications. Additionally, clinicians should advocate for broader awareness to prevent potentially fatal cardiomyopathy in these patients.

Frequently Asked Questions

Why is early screening for Chagas disease critical in infants?

Infants treated for Chagas disease in their first year of life show much higher cure rates compared to those treated later. Since the infection is often asymptomatic at birth, screening is the only way to ensure early intervention and prevent chronic cardiac or digestive complications.

How does maternal infection affect the risk of congenital Chagas?

Pregnant women with Trypanosoma cruzi infection have a 5% to 10% risk of transmitting the parasite to their offspring. Screening all children born to infected mothers is essential, especially in nonendemic settings where the disease is not routinely suspected.

Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a professional relationship. Always seek the advice of a qualified healthcare provider for any medical condition. Refer to the latest local and national guidelines for clinical practice.

References

1. Boté-Casamitjana A et al. Catch-Up Screening to Improve Detection of Congenital Chagas Disease in a Nonendemic Setting. Am J Trop Med Hyg. 2026 Feb 26. doi: undefined. PMID: 41747285.


2. Edwards MS, Montgomery SP. Congenital Chagas disease: progress toward implementation of pregnancy-based screening. Curr Opin Infect Dis. 2021 Oct 1;34(5):538-545.


3. World Health Organization. Preventing mother-to-child transmission of Chagas disease: from control to elimination. 2018 Nov 16.